Express Pharma
Browsing tag
GV Prasad
DRL posts Q2 FY17 and H1FY17 results
Read more
Dr Reddy’s to acquire Teva’s product portfolio for US Market
Read more
DRL posts consolidated revenues of Rs 37.6 billion, showing seven per cent growth YoY
Read more